Rutgers, The State University Of New Jersey Patent Portfolio Statistics

Rutgers, The State University Of New Jersey

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Rutgers, The State University Of New Jersey look like?

Total Applications: 1,484
Granted Patents: 1,021
Grant Index 78.42 %
Abandoned/Rejected Applications: 281 (21.58%)
In-Process Applications: 180
Average Grant Time: 3.0 Years
Average Office Actions: 1.82

Which Technology Area Rutgers, The State University Of New Jersey is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 47
1645 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 45
1661 Plants 37
1652 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 33
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs 31

How many patents are Rutgers, The State University Of New Jersey filing every year?

Year Total Applications
2022 0*
2021 43*
2020 55
2019 71
2018 76

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Rutgers, The State University Of New Jersey in USPTO?

Publication number:
Application number: 17/605,750

Abstract:
None

Publication date:
Applicant: Rutgers, The State University Of New Jersey
Inventors: A Gilleran John


Publication number: US20220002478A1
Application number: 17/475,914

Abstract:
The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomeric phenol compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processability are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric phenol compounds and biocompatible polymers.

Publication date: 2022-01-06
Applicant: Rutgers, The State University Of New Jersey
Inventors: Bolikal Durgadas


Publication number: US20210403520A1
Application number: 17/472,760

Abstract:
Inhibitors of interferon regulatory factor 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE) are described.

Publication date: 2021-12-30
Applicant: Rutgers, The State University Of New Jersey
Inventors: Barnes Betsy J


How are Rutgers, The State University Of New Jersey’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/605,750 Pharmaceutical Compounds And Therapeutic Methods Docketed New Case – Ready for Examination OPAP Central, Docket
17/475,914 Polymeric Biomaterials Derived From Phenolic Monomers And Their Medical Uses Docketed New Case – Ready for Examination OPAP Central, Docket
17/472,760 Cell Penetrating Peptides That Inhibit Irf5 Nuclear Localization Docketed New Case – Ready for Examination OPAP Central, Docket
17/465,011 Vehicular Information Systems And Methods Docketed New Case – Ready for Examination OPAP Central, Docket
17/398,606 In Vivo Radical-Mediated Polymerization For Targeted Delivery Of Trophic Factors Docketed New Case – Ready for Examination OPAP Central, Docket